Age-dependent differential responses of monoaminergic systems to high doses of methamphetamine

Journal of Neurochemistry

Volumn 75, Issue 5, 2000, Pages 2095-2102

  Kokoshka, J M ^a   Fleckenstein, A E ^a   Wilkins, D G ^a   Hanson, G R ^a  

^a UNIVERSITY OF UTAH   (United States)

Author keywords

Developmental; Dopamine; Methamphetamine; Neurotoxicity; Pharmacokineti c; Serotonin

Indexed keywords

DOPAMINE; DOPAMINE TRANSPORTER; METHAMPHETAMINE; SEROTONIN; TRYPTOPHAN HYDROXYLASE;

ADOLESCENCE; ADOLESCENT; AGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINE UPTAKE; DRUG ABUSE; DRUG MEGADOSE; ENZYME ACTIVITY; HYPERTHERMIA; MALE; MONOAMINERGIC SYSTEM; NEUROTOXICITY; NONHUMAN; PERINATAL DEVELOPMENT; PRIORITY JOURNAL; RAT; SEROTONINERGIC SYSTEM;

AGE FACTORS; AGING; AMPHETAMINE-RELATED DISORDERS; ANIMAL; BIOGENIC MONOAMINES; BRAIN; CARRIER PROTEINS; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEVER; FRONTAL LOBE; HIPPOCAMPUS; INJECTIONS, SUBCUTANEOUS; MALE; METHAMPHETAMINE; RATS; RATS, SPRAGUE-DAWLEY; SUPPORT, U.S. GOV'T, P.H.S.; SYNAPTOSOMES; TRYPTOPHAN HYDROXYLASE; TYROSINE 3-MONOOXYGENASE;

EID: 0033785570     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2000.0752095.x     Document Type: Article

References (40)

1. Methamphetamine-induced dopaminergic toxicity in mice. Role of environmental temperature and pharmacological agents
2. Immunocytochemical evidence for methamphetamine-induced serotonergic axon loss in the rat brain
3. Memory impairment in abstinent MDMA ('Ecstasy') users
4. Further studies of hyperthermia in methamphetamine neurotoxicity
5. Ontogeny of methamphetamine-induced neurotoxicity and associated hyperthermic response
6. Effects of LC mobile phase composition on retention times for biogenic amines, and their precursors and metabolites
7. Developmental changes in the catalytic activity and expression of CYP2D isoforms in the rat liver
8. A rapid and reversible change in dopamine transporters induced by methamphetamine
9. Rapid and reversible effects of methamphetamine on dopamine receptors
10. Interaction between hyperthermia and oxygen radical formation in the 5-hydroxytryptaminergic response to a single methamphetamine administration
11. Inactivation of constitutive hepatic cytochromes P450 by phencyclidine in the rat
12. Long-term effects of multiple doses of methamphetamine on tryptophan hydroxylase and tyrosine hydroxylase in rat brain
13. Role of the dopaminergic nigrostriatal pathway in methamphetamine-induced depression of the neostriatal serotonergic system
14. Effect of MK-801 on the decrease in tryptophan hydroxylase induced by methamphetamine and its methylenedioxy analog
15. Measurement of 5-hydroxytryptamine synthesis and metabolism in selected discrete regions of the rat brain using high performance liquid chromatography and electrochemical detection: Pharmacological manipulations
16. Nature of methamphetamine-induced rapid and reversible changes in dopamine transporters
17. Dopamine quinone formation and protein modification associated with the striatal neurotoxicity of methamphetamine: Evidence against a role for extracellular dopamine
18. Cytochrome P4502D isozymes catalyze the 4-hydroxylation of methamphetamine enantiomers
19. Selective mechanism-based inactivation of rat CYP2D by 4-allyloxymethamphetamine
20. Protein measurements with the Folin phenol reagent
21. Decreased sensitivity of rat pups to long-lasting dopamine and serotonin depletions produced by methamphetamine
22. 11C]WIN-35428
23. NSD 1034: An amino acid decarboxylase inhibitor with a stimulatory action on dopamine synthesis not mediated by classical dopamine receptors
24. Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: Immunocytochemical evidence for neurotoxicity
25. Recent advances in the endocrinology of puberty
26. Developmental dissociation of methamphetamine-induced depletion of dopaminergic terminals and astrocyte reaction in rat striatum
27. Dopamine nerve terminal degeneration produced by high doses of methylamphetamine in the rat brain
28. A high-dose methamphetamine regimen results in long-lasting deficits on the performance of a reaction time task
29. Histological and ultrastructural evidence that D-methamphetamine causes degeneration in neostriatum and frontal cortex of rats
30. Amphetamine analogs have differential effects on DRL 36-S schedule performance
31. Role of serotonin uptake carrier in the neurochemical response to methamphetamine: Effects of citalopram and chlorimipramine
32. Formation of 6-hydroxydopamine in caudate nucleus of the rat brain after a single large dose of methylamphetamine
33. Roles of D-1 and D-2 dopamine receptor subtypes in mediating the methamphetamine-induced changes in monoamine systems
34. In vitro reactivation of rat cortical tryptophan hydroxylase following in vivo inactivation by methylenedioxymethamphetamine
35. Long-lasting depletions of striatal dopamine and loss of dopamine uptake sites following repeated administration of methamphetamine
36. Neurochemical consequences following administration of CNS stimulants to the neonatal rat
37. Striatal dopamine nerve terminal markers in human, chronic methamphetamine users
38. Long-term effects of chronic methamphetamine administration in rhesus monkeys